The place of Cetraria islandica in the treatment of acute respiratory viral infection


DOI: https://dx.doi.org/10.18565/pharmateca.2021.10.117-123

I.L. Klyachkina

Russian Medical Academy of Continuous Professional Education, Moscow, Russia
Acute respiratory viral infections (ARVI) are a large etiologically heterogeneous group of infectious diseases occurring with damage to the upper and lower respiratory tract. The development of the inflammatory process in the mucous membrane of the respiratory tract in ARVI significantly increases the sensitivity of the cough receptors, which decreases when the inflammation is stopped. The new concept of the pathogenesis of cough as a manifestation of hypersensitivity assumes that the basis of treatment is drugs that demonstrate both anti-inflammatory and antitussive properties. As a rule, phytopreparations intended for the treatment of cough have such a combination of effects. These drugs are more effective, they are characterized by prolonged and multidirectional pharmacological action.
Keywords: acute respiratory viral infections, damage to the upper and lower respiratory tract, cough

About the Autors


Corresponding author: Irina L. Klyachkina, Cand. Sci. (Med.), Associate Professor at the Department of Pulmonology, Russian Medical Academy of Continuous Professional Education, Moscow, Russia; e-mail: formozailk2012@yandex.ru
Address: build. 1, 2/1 Barrikadnaya st., Moscow 125993, Russian Federation


Бионика Медиа